What is the recommended treatment for vaginal herpes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Vaginal Herpes

The recommended treatment for vaginal herpes includes acyclovir 400 mg orally three times daily for 7-10 days, valacyclovir 1 g orally twice daily for 7-10 days, or famciclovir 250 mg orally three times daily for 7-10 days for first clinical episodes, with shorter courses for recurrent episodes and daily suppressive therapy options for frequent recurrences. 1, 2

First Clinical Episode Treatment

  • For initial genital herpes episodes, treatment should be initiated as soon as possible after symptom onset, ideally within 48-72 hours 1
  • Recommended regimens include:
    • Acyclovir 400 mg orally three times daily for 7-10 days 1
    • Acyclovir 200 mg orally five times daily for 7-10 days 1
    • Famciclovir 250 mg orally three times daily for 7-10 days 1
    • Valacyclovir 1 g orally twice daily for 7-10 days 1, 3
  • Treatment may be extended if healing is incomplete after 10 days 1

Recurrent Episodes Treatment

  • Episodic therapy is most effective when started during the prodrome or within 1 day after onset of lesions 1, 2
  • Recommended regimens for recurrent episodes:
    • Acyclovir 400 mg orally three times daily for 5 days 1, 2
    • Acyclovir 800 mg orally twice daily for 5 days 1, 2
    • Acyclovir 200 mg orally five times daily for 5 days 1, 2
    • Famciclovir 125 mg orally twice daily for 5 days 1, 2
    • Valacyclovir 500 mg orally twice daily for 5 days 1, 2, 3

Suppressive Therapy

  • Daily suppressive therapy should be considered for patients with frequent recurrences (≥6 episodes per year) 1, 2
  • Suppressive therapy reduces recurrence frequency by ≥75% and reduces asymptomatic viral shedding 1, 2
  • Recommended regimens for suppressive therapy:
    • Acyclovir 400 mg orally twice daily 1, 2
    • Famciclovir 250 mg orally twice daily 1, 2
    • Valacyclovir 1 g orally once daily 1, 2, 3
    • Valacyclovir 500 mg orally once daily (for patients with <9 recurrences per year) 1, 2, 3
  • For HIV-infected patients with CD4+ count ≥100 cells/mm³, valacyclovir 500 mg twice daily is recommended 3

Important Counseling Points

  • Patients should be informed that genital herpes is a recurrent, incurable viral disease 1, 2
  • Advise abstaining from sexual activity when lesions or prodromal symptoms are present 1, 2
  • Encourage informing sex partners about having genital herpes 1, 2
  • Recommend condom use during all sexual exposures with new or uninfected partners 1, 2
  • Explain that asymptomatic viral shedding can occur, potentially leading to transmission even without symptoms 1, 2
  • Explain the risk of neonatal infection to all patients, including men 1

Treatment Considerations and Pitfalls

  • Topical acyclovir is substantially less effective than oral therapy and is not recommended 1, 4
  • Valacyclovir is the only antiviral approved for once-daily suppressive therapy and for a 3-day regimen of episodic treatment 5
  • After 1 year of continuous suppressive therapy, consider discontinuation to assess recurrence frequency 1, 2
  • Safety and efficacy have been documented for acyclovir for up to 6 years, and for valacyclovir and famciclovir for 1 year 1
  • Valacyclovir 500 mg once daily may be less effective for patients with very frequent recurrences (≥10 episodes per year) 1, 6

Special Populations

  • For pregnant women, discuss the risk of neonatal herpes with healthcare providers during pregnancy 1
  • For immunocompromised patients with severe disease, consider intravenous antiviral therapy 4
  • For acyclovir-resistant cases, intravenous foscarnet or cidofovir may be used 4, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Recurrent Genital Herpes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Shingles with Antiviral Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Valacyclovir for the treatment of genital herpes.

Expert review of anti-infective therapy, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.